🔎 Trials Near Me

Home › Obstructive Sleep Apnea › NCT04457154

Pediatric Post-Approval Registry

RecruitingObservational study

Inspire Pediatric Post-Approval Registry

Who can join

Ages 18 to 21 · All sexes

Full eligibility criteria
Inclusion Criteria:

1. Subject is between 18 and 21 years of age;
2. Subject has a diagnosis of moderate to severe OSA (15 ≤ AHI ≤ 65) based on a recent sleep study;
3. Subject has documented failure of, or intolerance to, positive airway pressure treatments, despite attempts to improve compliance;
4. Subject is contraindicated for, or not effectively treated by, adenotonsillectomy;
5. Subject has followed standard of care in considering all other alternative/adjunct therapies;
6. Subject is willing and able to have stimulation hardware permanently implanted and to use the patient remote to activate the stimulation;
7. Subject is willing and able to return for follow-up visits, undergo sleep studies (including in-lab and at-home), and complete questionnaires related to the registry;
8. Subject is willing and able to provide informed consent.

Exclusion Criteria:

1. Subject has a combination of central + mixed apneas \> 25% of the total apnea-hypopnea index (AHI);
2. Subject has any anatomical finding that would compromise the performance of upper airway stimulation, such as the presence of complete concentric collapse of the soft palate;
3. Subject has any condition or procedure that has compromised neurological control of the upper airway;
4. Subject is unable, or does not have the necessary assistance, to operate the patient remote;
5. Subject is pregnant or plans to become pregnant;
6. Subject has an implantable device that may be susceptible to unintended interaction with the Inspire System;
7. Subject has a terminal illness with life expectancy \< 12 months;
8. Any other reason the investigator deems the subject is unfit for participation in the registry.

About the study

This registry is a prospective, multi-center, single-arm study of pediatric subjects (ages 18-21 years) who are undergoing implant of the Inspire Upper Airway Stimulation (UAS) System for the treatment of moderate or severe obstructive sleep apnea (OSA). Implanted subjects will be followed for 5 years post-implant.

What is being tested

Sponsor: Inspire Medical Systems, Inc. · Participants: 60 · Started: Nov 30, 2021

Contact the study team

Official record on ClinicalTrials.gov — NCT04457154

Locations in the U.S.

ColoradoChildrens Hospital of Colorado, Aurora
North CarolinaDuke University, Durham
OhioCincinnati Childrens Hospital, Cincinnati
PennsylvaniaChildren's Hospital of Philadelphia, Philadelphia
Children's Hospital of Pittsburgh, Sewickley
TexasUniversity of Texas Southwestern/Children's Hospital of Dallas, Dallas
VirginiaChildren's Hospital of the King's Daughters/East Virginia Medical School, Norfolk

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.